Pharmaceuticals

Outlook for Synthetic Hormones Market: Key Developments and Future Strategies to 2029

September 1, 2025 by Marketing Posting

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Is the Current and Projected Market Size of the Synthetic Hormones Industry?#_x000D_

The size of the cyclosporine market has seen massive expansion in the past few years. There’s a predicted escalation from $2.65 billion in 2024 to $2.98 billion in 2025, with a compound annual growth rate (CAGR) of 12.6%. The growth observed in the historical period can be attributed to factors such as the escalating number of organ transplants, rising autoimmune conditions, increasing chronic diseases, kidney disorders on the upswing, and the proliferation of transplant centers._x000D_

_x000D_

In the coming years, the cyclosporine market size is predicted to grow rapidly. It is anticipated to reach “$4.85 billion in 2029, with a compound annual growth rate (CAGR) of 12.9%. The expansion during the forecast period is expected to be fuelled by increasing organ donations, the widespread application of immunotherapy, a growing aging patient population, a burgeoning specialty pharmaceutical market, and an increased prevalence of rheumatoid arthritis. Key trends projected for the forecast period include the creation of new immunosuppressive treatments, the innovation of AI-driven drug development, advancements in nanotechnology integration, the application of blockchain in managing drug supply chains, and improvements in drug delivery methods._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=23360&type=smp_x000D_

_x000D_

#Which Factors Are Currently Driving The Growth Of The Synthetic Hormones Market?_x000D_

The surge in the occurrence of hormonal imbalances is anticipated to drive the expansion of the synthetic hormones market. Hormonal imbalance is characterized by a high or low level of a certain hormone in the bloodstream, an anomaly that can result from stress, age, certain diseases, or lifestyle choices, disrupting the normal generation and control of body hormones. Synthetic hormones are deployed to augment or replace natural hormones during hormonal imbalances, enabling regulation of bodily functions and the reduction of symptoms associated with hormonal deficiencies or oversupply. To illustrate, the NHS Business Services Authority, a non-departmental public body based in the UK, stated that around 7.80 million Hormone Replacement Therapy (HRT) items were prescribed in England in 2022, representing a 35.0% rise from the last year. Consequently, the surge in the occurrence of hormonal imbalances is fostering the expansion of the synthetic hormones market._x000D_

_x000D_

The cyclosporine market covered in this report is segmented – _x000D_

_x000D_

1) By Indication: Transplant Rejection Prophylaxis, Rheumatoid Arthritis, Psoriasis, Autoimmune Myasthenia Gravis, Dry Eye, Other Indications_x000D_

2) By Dosage Form: Capsule, Eye Drops, Liquid Solutions, Creams And Ointments_x000D_

3) By Route Of Administration: Oral, Topical, Parenteral_x000D_

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies_x000D_

5) By End-Users: Hospitals, Homecare, Speciality Centres, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Transplant Rejection Prophylaxis: Kidney Transplant, Liver Transplant, Heart Transplant, Lung Transplant, Other Transplants_x000D_

2) By Rheumatoid Arthritis: Moderate Rheumatoid Arthritis, Severe Rheumatoid Arthritis_x000D_

3) By Psoriasis: Plaque Psoriasis, Erythrodermic Psoriasis, Guttate Psoriasis, Pustular Psoriasis_x000D_

4) By Autoimmune Myasthenia Gravis: Generalized Myasthenia Gravis, Ocular Myasthenia Gravis_x000D_

5) By Dry Eye: Chronic Dry Eye, Severe Dry Eye_x000D_

6) By Other Indications: Atopic Dermatitis, Uveitis, Nephrotic Syndrome, Inflammatory Bowel Disease (IBD)_x000D_

_x000D_

#What Upcoming Trends Are Expected To Impact The Synthetic Hormones Market Globally?#_x000D_

Leading firms in the cyclosporine market are concentrating on acquiring regulatory permissions to broaden their product range and strengthen their position in the market. Such approvals authenticate the safety and efficacy of cyclosporine, thus enhancing its acceptance and instilling confidence among prescribers and patients. For example, in June 2023, Novaliq GmbH, a biopharmaceutical firm based in Germany, secured U.S. FDA’s approval for VEVYE (cyclosporine ophthalmic solution) 0.1%, an innovative water-free ophthalmic medicine designed to treat dry eye disease (DED). It is the first and only cyclosporine solution for this ailment, exhibiting effectiveness in just four weeks. The technology used in VEVYE is the groundbreaking water-free EyeSol, which escalates cyclosporine’s bioavailability and dwell time on the ocular surface without resorting to preservatives, oils, or surfactants. The solution operates as a calcineurin inhibitor, aiding in the reduction of inflammation related to dry eye disease._x000D_

_x000D_

#Who Are The Main Participants Shaping The Synthetic Hormones Market Landscape?#_x000D_

Major companies operating in the cyclosporine market are Novartis AG, Viatris Inc., Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd, Apotex Inc., Cipla Ltd, Dr. Reddy’s Laboratories Ltd, Lupin Limited, Glenmark Pharmaceuticals Ltd, Taj Pharmaceuticals Limited, Panacea Biotec Ltd, Novaliq GmbH, Simson Pharma Limited, Strides Pharma Science Ltd, AdvaCare Pharma, JoinHub Pharma, Grevis Pharmaceuticals Pvt Ltd, GMT Pharma International, Logos Pharma. _x000D_

_x000D_

https://www.thebusinessresearchcompany.com/report/cyclosporine-global-market-report_x000D_

_x000D_

#Which Region Currently Holds The Largest Share In The Synthetic Hormones Market?#_x000D_

Asia-Pacific was the largest region in the cyclosporine market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cyclosporine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=23360&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_